Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Since the end of 2019, global healthcare systems have been dealing with the COVID-19 pandemic. In oncology, the biggest questions concern interaction of COVID-19 with pre-existing cancer disease and with systemic anticancer treatments. With regards to immunotherapy, there is uncertainty about its ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Saponara, Maristella, Pala, Laura, Conforti, Fabio, Rubatto, Marco, De Risi, Ivana, Spagnolo, Francesco, Guida, Michele, Bossi, Paolo, Quaglino, Pietro, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684275/
https://www.ncbi.nlm.nih.gov/pubmed/33273966
http://dx.doi.org/10.1177/1758835920977002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684275/
https://www.ncbi.nlm.nih.gov/pubmed/33273966
http://dx.doi.org/10.1177/1758835920977002

Ejemplares similares